Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual MeetingBusiness
Bausch + Lomb Reports More Than 48 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling ProgramsBusiness
RECOVERY CENTERS OF AMERICA AND MAPDA (MOTHERS AGAINST PRESCRIPTION DRUG ABUSE) 2022 SCHOLARSHIP WINNERS COMMITTED TO THE FIGHT AGAINST ADDICTIONBusiness
Bausch + Lomb Corporation Seeking to Enter Into New Credit Facilities to Facilitate Previously Announced Separation from Bausch HealthBusiness
Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual MeetingBusiness
